132 related articles for article (PubMed ID: 26210486)
1. Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells.
Power Coombs MR; Grant T; Greenshields AL; Arsenault DJ; Holbein BE; Hoskin DW
Exp Mol Pathol; 2015 Oct; 99(2):262-70. PubMed ID: 26210486
[TBL] [Abstract][Full Text] [Related]
2. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.
Greenshields AL; Power Coombs MR; Fernando W; Holbein BE; Hoskin DW
Biometals; 2019 Dec; 32(6):909-921. PubMed ID: 31624972
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
4. Effect of trace iron levels and iron withdrawal by chelation on the growth of Candida albicans and Candida vini.
Holbein BE; Mira de Orduña R
FEMS Microbiol Lett; 2010 Jun; 307(1):19-24. PubMed ID: 20402789
[TBL] [Abstract][Full Text] [Related]
5. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
Hoke EM; Maylock CA; Shacter E
Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
[TBL] [Abstract][Full Text] [Related]
6. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.
Simonart T; Degraef C; Andrei G; Mosselmans R; Hermans P; Van Vooren JP; Noel JC; Boelaert JR; Snoeck R; Heenen M
J Invest Dermatol; 2000 Nov; 115(5):893-900. PubMed ID: 11069629
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
[TBL] [Abstract][Full Text] [Related]
8. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.
Bajbouj K; Shafarin J; Hamad M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764470. PubMed ID: 29562821
[TBL] [Abstract][Full Text] [Related]
10. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
11. Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells.
Das M; Kandimalla R; Gogoi B; Dutta KN; Choudhury P; Devi R; Dutta PP; Talukdar NC; Samanta SK
Pharmacol Res; 2019 Aug; 146():104330. PubMed ID: 31251988
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
13. Novel Iron-Chelator DIBI Inhibits
Parquet MDC; Savage KA; Allan DS; Davidson RJ; Holbein BE
Front Microbiol; 2018; 9():1811. PubMed ID: 30154764
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
Islam S; Jarosch S; Zhou J; Parquet Mdel C; Toguri JT; Colp P; Holbein BE; Lehmann C
J Surg Res; 2016 Jan; 200(1):266-73. PubMed ID: 26235905
[TBL] [Abstract][Full Text] [Related]
15. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Brard L; Granai CO; Swamy N
Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
[TBL] [Abstract][Full Text] [Related]
16. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
18. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
19. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2.
Sun X; Ge R; Cai Z; Sun H; He QY
J Inorg Biochem; 2009 Jul; 103(7):1074-81. PubMed ID: 19515424
[TBL] [Abstract][Full Text] [Related]
20. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
Kim JA; Kim DH; Hossain MA; Kim MY; Sung B; Yoon JH; Suh H; Jeong TC; Chung HY; Kim ND
Int J Oncol; 2014 Feb; 44(2):473-80. PubMed ID: 24316714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]